Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the Spanish National Research Council is evaluating erythrodiol in pomace olive oil as a protective agent against atherosc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythrodiol (erythrodiol)

Snippet

Sponsor: Spanish National Research Council | Conditions: Atherosclerosis Cardiovascular Disease | Phase 2 | Status: NOT_YET_RECRUITING